Old ideas to innovate tuberculosis control

Preventive treatment to achieve elimination

Roland Diel, Robert Loddenkemper, Jean Pierre Zellweger, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marieke J. Van Der Werf, Masoud Dara, Anne Detjen, Peter Gondrie, Lee Reichman, Francesco Blasi, Giovanni Battista Migliori

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

The introduction of new rapid diagnostic tools for tuberculosis (TB) and the promising TB drugs pipeline together with the development of a new World Health Organization Strategy post 2015 allows new discussions on how to direct TB control. The European Respiratory Society's European Forum for TB Innovation was created to stimulate discussion on how to best take advantage of old and new opportunities, and advances, to improve TB control and eventually progress towards the elimination of TB. While TB control is aimed at reducing the incidence of TB by early diagnosis and treatment of infectious cases of TB, TB elimination requires focus on sterilising the pool of latently infected individuals, from which future TB cases would be generated. This manuscript describes the three core components that are necessary to implement the elimination strategy fully. 1) Improve diagnosis of latent TB infected individuals. 2) Improve regimens to treat latent TB infection. 3) ensure public health commitment to make both 1) and 2) possible. Old and new evidence is critically described, focusing on the European commitment to reach elimination and on the innovative experiences and best practices available.

Original languageEnglish
Pages (from-to)785-801
Number of pages17
JournalEuropean Respiratory Journal
Volume42
Issue number3
DOIs
Publication statusPublished - Sep 1 2013

Fingerprint

Tuberculosis
Latent Tuberculosis
Practice Guidelines
Early Diagnosis
Public Health
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Old ideas to innovate tuberculosis control : Preventive treatment to achieve elimination. / Diel, Roland; Loddenkemper, Robert; Zellweger, Jean Pierre; Sotgiu, Giovanni; D'Ambrosio, Lia; Centis, Rosella; Van Der Werf, Marieke J.; Dara, Masoud; Detjen, Anne; Gondrie, Peter; Reichman, Lee; Blasi, Francesco; Migliori, Giovanni Battista.

In: European Respiratory Journal, Vol. 42, No. 3, 01.09.2013, p. 785-801.

Research output: Contribution to journalArticle

Diel, R, Loddenkemper, R, Zellweger, JP, Sotgiu, G, D'Ambrosio, L, Centis, R, Van Der Werf, MJ, Dara, M, Detjen, A, Gondrie, P, Reichman, L, Blasi, F & Migliori, GB 2013, 'Old ideas to innovate tuberculosis control: Preventive treatment to achieve elimination', European Respiratory Journal, vol. 42, no. 3, pp. 785-801. https://doi.org/10.1183/09031936.00205512
Diel, Roland ; Loddenkemper, Robert ; Zellweger, Jean Pierre ; Sotgiu, Giovanni ; D'Ambrosio, Lia ; Centis, Rosella ; Van Der Werf, Marieke J. ; Dara, Masoud ; Detjen, Anne ; Gondrie, Peter ; Reichman, Lee ; Blasi, Francesco ; Migliori, Giovanni Battista. / Old ideas to innovate tuberculosis control : Preventive treatment to achieve elimination. In: European Respiratory Journal. 2013 ; Vol. 42, No. 3. pp. 785-801.
@article{201cea6e06af481eaf719ebdc73f7466,
title = "Old ideas to innovate tuberculosis control: Preventive treatment to achieve elimination",
abstract = "The introduction of new rapid diagnostic tools for tuberculosis (TB) and the promising TB drugs pipeline together with the development of a new World Health Organization Strategy post 2015 allows new discussions on how to direct TB control. The European Respiratory Society's European Forum for TB Innovation was created to stimulate discussion on how to best take advantage of old and new opportunities, and advances, to improve TB control and eventually progress towards the elimination of TB. While TB control is aimed at reducing the incidence of TB by early diagnosis and treatment of infectious cases of TB, TB elimination requires focus on sterilising the pool of latently infected individuals, from which future TB cases would be generated. This manuscript describes the three core components that are necessary to implement the elimination strategy fully. 1) Improve diagnosis of latent TB infected individuals. 2) Improve regimens to treat latent TB infection. 3) ensure public health commitment to make both 1) and 2) possible. Old and new evidence is critically described, focusing on the European commitment to reach elimination and on the innovative experiences and best practices available.",
author = "Roland Diel and Robert Loddenkemper and Zellweger, {Jean Pierre} and Giovanni Sotgiu and Lia D'Ambrosio and Rosella Centis and {Van Der Werf}, {Marieke J.} and Masoud Dara and Anne Detjen and Peter Gondrie and Lee Reichman and Francesco Blasi and Migliori, {Giovanni Battista}",
year = "2013",
month = "9",
day = "1",
doi = "10.1183/09031936.00205512",
language = "English",
volume = "42",
pages = "785--801",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - Old ideas to innovate tuberculosis control

T2 - Preventive treatment to achieve elimination

AU - Diel, Roland

AU - Loddenkemper, Robert

AU - Zellweger, Jean Pierre

AU - Sotgiu, Giovanni

AU - D'Ambrosio, Lia

AU - Centis, Rosella

AU - Van Der Werf, Marieke J.

AU - Dara, Masoud

AU - Detjen, Anne

AU - Gondrie, Peter

AU - Reichman, Lee

AU - Blasi, Francesco

AU - Migliori, Giovanni Battista

PY - 2013/9/1

Y1 - 2013/9/1

N2 - The introduction of new rapid diagnostic tools for tuberculosis (TB) and the promising TB drugs pipeline together with the development of a new World Health Organization Strategy post 2015 allows new discussions on how to direct TB control. The European Respiratory Society's European Forum for TB Innovation was created to stimulate discussion on how to best take advantage of old and new opportunities, and advances, to improve TB control and eventually progress towards the elimination of TB. While TB control is aimed at reducing the incidence of TB by early diagnosis and treatment of infectious cases of TB, TB elimination requires focus on sterilising the pool of latently infected individuals, from which future TB cases would be generated. This manuscript describes the three core components that are necessary to implement the elimination strategy fully. 1) Improve diagnosis of latent TB infected individuals. 2) Improve regimens to treat latent TB infection. 3) ensure public health commitment to make both 1) and 2) possible. Old and new evidence is critically described, focusing on the European commitment to reach elimination and on the innovative experiences and best practices available.

AB - The introduction of new rapid diagnostic tools for tuberculosis (TB) and the promising TB drugs pipeline together with the development of a new World Health Organization Strategy post 2015 allows new discussions on how to direct TB control. The European Respiratory Society's European Forum for TB Innovation was created to stimulate discussion on how to best take advantage of old and new opportunities, and advances, to improve TB control and eventually progress towards the elimination of TB. While TB control is aimed at reducing the incidence of TB by early diagnosis and treatment of infectious cases of TB, TB elimination requires focus on sterilising the pool of latently infected individuals, from which future TB cases would be generated. This manuscript describes the three core components that are necessary to implement the elimination strategy fully. 1) Improve diagnosis of latent TB infected individuals. 2) Improve regimens to treat latent TB infection. 3) ensure public health commitment to make both 1) and 2) possible. Old and new evidence is critically described, focusing on the European commitment to reach elimination and on the innovative experiences and best practices available.

UR - http://www.scopus.com/inward/record.url?scp=84880142045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880142045&partnerID=8YFLogxK

U2 - 10.1183/09031936.00205512

DO - 10.1183/09031936.00205512

M3 - Article

VL - 42

SP - 785

EP - 801

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 3

ER -